Biogen (NASDAQ:BIIB – Free Report) had its price target decreased by Needham & Company LLC from $305.00 to $300.00 in a research report released on Tuesday, MarketBeat reports. Needham & Company LLC currently has a buy rating on the biotechnology company’s stock. Other equities research analysts have also issued reports about the stock. Wells Fargo […]
Biogen (NASDAQ:BIIB – Free Report) had its price objective cut by Piper Sandler from $350.00 to $325.00 in a research report sent to investors on Wednesday morning, Benzinga reports. They currently have an overweight rating on the biotechnology company’s stock. BIIB has been the topic of a number of other reports. BTIG Research reaffirmed a […]
Biogen Inc. (NASDAQ:BIIB – Get Free Report) insider Priya Singhal sold 419 shares of Biogen stock in a transaction that occurred on Monday, February 12th. The stock was sold at an average price of $239.45, for a total transaction of $100,329.55. Following the transaction, the insider now owns 4,516 shares in the company, valued at […]
Biogen (NASDAQ:BIIB – Get Free Report) issued an update on its FY24 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $15.00-$16.00 for the period, compared to the consensus earnings per share estimate of $15.81. Biogen also updated its FY 2024 guidance to 15.000-16.000 EPS. Biogen Stock Down 1.6 % Shares […]
Biogen (NASDAQ:BIIB – Get Free Report) updated its FY 2024 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 15.000-16.000 for the period, compared to the consensus estimate of 15.650. The company issued revenue guidance of -. Biogen also updated its FY24 guidance to $15.00-$16.00 EPS. Biogen Stock Down 1.9 % […]